Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date

Rebecca Howell,1 Adrienne M Wright,1 Jennifer N Clements2 1Presbyterian College School of Pharmacy, Clinton, SC 29325, USA; 2Department of Pharmacy Practice, Presbyterian College School of Pharmacy, Clinton, SC 29325, USA Abstract: Metformin is the first-line therapy for the management of type 2 dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Howell R, Wright AM, Clements JN
Format: article
Language:EN
Published: Dove Medical Press 2019
Subjects:
Online Access:https://doaj.org/article/418b5a932ce94726935dae48e2b6e826
Tags: Add Tag
No Tags, Be the first to tag this record!